|
US603112A
(en)
|
|
1898-04-26 |
|
Electric lamp |
|
US55458A
(en)
|
|
1866-06-12 |
|
Aldee beigham |
|
US545806A
(en)
|
|
1895-09-03 |
|
Trolley-wire support |
|
US928944A
(en)
|
1908-08-27 |
1909-07-27 |
Carl B Davenport |
Buckle.
|
|
US4237115A
(en)
|
1977-11-23 |
1980-12-02 |
Bactex, Inc. |
Method of immunization against enterotoxogenic infection by Escherichia coli
|
|
US4235871A
(en)
|
1978-02-24 |
1980-11-25 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4397844A
(en)
|
1978-02-24 |
1983-08-09 |
Ciba-Geigy Corporation |
Antigen derivatives and processes for their preparation
|
|
GB2026340B
(en)
|
1978-07-03 |
1982-12-22 |
Ash P |
Stabilising microvesicles
|
|
US4681762A
(en)
|
1979-05-23 |
1987-07-21 |
Research Corporation |
Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
|
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
|
US4714681A
(en)
|
1981-07-01 |
1987-12-22 |
The Board Of Reagents, The University Of Texas System Cancer Center |
Quadroma cells and trioma cells and methods for the production of same
|
|
US4769330A
(en)
|
1981-12-24 |
1988-09-06 |
Health Research, Incorporated |
Modified vaccinia virus and methods for making and using the same
|
|
US4603112A
(en)
|
1981-12-24 |
1986-07-29 |
Health Research, Incorporated |
Modified vaccinia virus
|
|
US4593002A
(en)
|
1982-01-11 |
1986-06-03 |
Salk Institute Biotechnology/Industrial Associates, Inc. |
Viruses with recombinant surface proteins
|
|
US4501728A
(en)
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4592002A
(en)
|
1983-12-13 |
1986-05-27 |
Honeywell Inc. |
Method of digital temperature compensation and a digital data handling system utilizing the same
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
ZA858044B
(en)
|
1984-11-01 |
1987-05-27 |
American Home Prod |
Oral vaccines
|
|
AU584417B2
(en)
|
1985-04-01 |
1989-05-25 |
Lonza Group Ag |
Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same
|
|
FR2583429B1
(fr)
|
1985-06-18 |
1989-11-03 |
Transgene Sa |
Vecteur d'expression de l'interferon u dans les cellules de mammifere, procede pour sa mise en oeuvre et produit obtenu et composition pharmaceutique contenant l'interferon u
|
|
JPS63501765A
(ja)
|
1985-11-01 |
1988-07-21 |
インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド |
抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
|
|
GB8601597D0
(en)
|
1986-01-23 |
1986-02-26 |
Wilson R H |
Nucleotide sequences
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
DE3642912A1
(de)
|
1986-12-16 |
1988-06-30 |
Leybold Ag |
Messeinrichtung fuer paramagnetische messgeraete mit einer messkammer
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
GB8717430D0
(en)
|
1987-07-23 |
1987-08-26 |
Celltech Ltd |
Recombinant dna product
|
|
US4925648A
(en)
|
1988-07-29 |
1990-05-15 |
Immunomedics, Inc. |
Detection and treatment of infectious and inflammatory lesions
|
|
US5601819A
(en)
|
1988-08-11 |
1997-02-11 |
The General Hospital Corporation |
Bispecific antibodies for selective immune regulation and for selective immune cell binding
|
|
US4975271A
(en)
|
1988-12-19 |
1990-12-04 |
Vipont Pharmaceutical, Inc. |
Muscosal delivery systems for treatment of periodontal disease
|
|
US5744166A
(en)
|
1989-02-25 |
1998-04-28 |
Danbiosyst Uk Limited |
Drug delivery compositions
|
|
EP0394827A1
(en)
|
1989-04-26 |
1990-10-31 |
F. Hoffmann-La Roche Ag |
Chimaeric CD4-immunoglobulin polypeptides
|
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
|
ES2096590T3
(es)
|
1989-06-29 |
1997-03-16 |
Medarex Inc |
Reactivos biespecificos para la terapia del sida.
|
|
US5413923A
(en)
|
1989-07-25 |
1995-05-09 |
Cell Genesys, Inc. |
Homologous recombination for universal donor cells and chimeric mammalian hosts
|
|
FR2650598B1
(fr)
|
1989-08-03 |
1994-06-03 |
Rhone Poulenc Sante |
Derives de l'albumine a fonction therapeutique
|
|
US5676954A
(en)
|
1989-11-03 |
1997-10-14 |
Vanderbilt University |
Method of in vivo delivery of functioning foreign genes
|
|
US5100587A
(en)
|
1989-11-13 |
1992-03-31 |
The United States Of America As Represented By The Department Of Energy |
Solid-state radioluminescent zeolite-containing composition and light sources
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5814318A
(en)
|
1990-08-29 |
1998-09-29 |
Genpharm International Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
AU667460B2
(en)
|
1990-10-05 |
1996-03-28 |
Medarex, Inc. |
Targeted immunostimulation with bispecific reagents
|
|
EP0557300B1
(en)
|
1990-10-29 |
1997-11-19 |
Chiron Corporation |
Bispecific antibodies, method of production, and uses thereof
|
|
US5179993A
(en)
|
1991-03-26 |
1993-01-19 |
Hughes Aircraft Company |
Method of fabricating anisometric metal needles and birefringent suspension thereof in dielectric fluid
|
|
IE921342A1
(en)
|
1991-04-26 |
1992-11-04 |
Surface Active Ltd |
Novel antibodies, and methods for their use
|
|
SE503225C2
(sv)
|
1991-10-30 |
1996-04-22 |
Leif Lindholm Konsult Ab |
Virus-antikroppskomplex för införing av virus i mammalieceller
|
|
US5661133B1
(en)
|
1991-11-12 |
1999-06-01 |
Univ Michigan |
Collateral blood vessel formation in cardiac muscle by injecting a dna sequence encoding an angiogenic protein
|
|
ES2341666T3
(es)
|
1991-12-02 |
2010-06-24 |
Medimmune Limited |
Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
|
|
FR2686899B1
(fr)
|
1992-01-31 |
1995-09-01 |
Rhone Poulenc Rorer Sa |
Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
|
|
EP1306095A3
(en)
|
1992-03-05 |
2003-06-25 |
Board Of Regents, The University Of Texas System |
Methods and compositions for targeting the vasculature of solid tumors
|
|
ATE182651T1
(de)
|
1992-06-09 |
1999-08-15 |
Hoppe Ag |
Riegel und türschloss
|
|
WO1994010958A1
(en)
|
1992-11-13 |
1994-05-26 |
Mitchell Winalee G |
Absorbent including super absorbent and capacity monitor
|
|
US5747323A
(en)
|
1992-12-31 |
1998-05-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Retroviral vectors comprising a VL30-derived psi region
|
|
US5633234A
(en)
|
1993-01-22 |
1997-05-27 |
The Johns Hopkins University |
Lysosomal targeting of immunogens
|
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
|
FR2707091B1
(fr)
|
1993-06-30 |
1997-04-04 |
Cohen Haguenauer Odile |
Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes.
|
|
US5928944A
(en)
|
1994-02-04 |
1999-07-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of adenoviral-medicated cell transfection
|
|
FI955320A7
(fi)
|
1994-03-07 |
1995-11-24 |
Univ Michigan |
Bioaktiivisia ja/tai kohdennettuja dendriimikonjugaatteja
|
|
WO1995028494A1
(en)
|
1994-04-15 |
1995-10-26 |
Targeted Genetics Corporation |
Gene delivery fusion proteins
|
|
FR2719316B1
(fr)
|
1994-04-28 |
1996-05-31 |
Idm |
Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules.
|
|
AU2946295A
(en)
|
1994-06-27 |
1996-01-19 |
Johns Hopkins University, The |
Targeted gene delivery system
|
|
FR2722506B1
(fr)
|
1994-07-13 |
1996-08-14 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucleiques, preparation et utilisations
|
|
FR2727689A1
(fr)
|
1994-12-01 |
1996-06-07 |
Transgene Sa |
Nouveau procede de preparation d'un vecteur viral
|
|
EP1323346B1
(en)
|
1995-01-17 |
2006-06-28 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of immunogens
|
|
US6030613A
(en)
|
1995-01-17 |
2000-02-29 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5837520A
(en)
|
1995-03-07 |
1998-11-17 |
Canji, Inc. |
Method of purification of viral vectors
|
|
CA2219361C
(en)
|
1995-04-27 |
2012-02-28 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
EP0823941A4
(en)
|
1995-04-28 |
2001-09-19 |
Abgenix Inc |
HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
|
|
FR2737222B1
(fr)
|
1995-07-24 |
1997-10-17 |
Transgene Sa |
Nouveaux vecteurs viraux et lignee pour la therapie genique
|
|
WO1997035996A1
(en)
|
1996-03-25 |
1997-10-02 |
Transgene S.A. |
Packaging cell line based on human 293 cells
|
|
EP0944717A1
(fr)
|
1996-07-01 |
1999-09-29 |
Aventis Pharma S.A. |
Procede de production d'adenovirus recombinants
|
|
EP0920339A2
(en)
|
1996-07-09 |
1999-06-09 |
The Johns Hopkins University |
Gene delivery system
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
EP1500329B1
(en)
|
1996-12-03 |
2012-03-21 |
Amgen Fremont Inc. |
Human antibodies that specifically bind human TNF alpha
|
|
ATE477320T1
(de)
|
1996-12-13 |
2010-08-15 |
Schering Corp |
Methoden zur virus-reinigung
|
|
FR2759382A1
(fr)
|
1997-02-10 |
1998-08-14 |
Transgene Sa |
Nouveaux composes et compositions les contenant utilisables pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique
|
|
FR2760193B1
(fr)
|
1997-02-28 |
1999-05-28 |
Transgene Sa |
Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
|
|
FR2763958A1
(fr)
|
1997-05-29 |
1998-12-04 |
Transgene Sa |
Produit de combinaison associant un acide nucleique a une substance desorganisant la matrice extracellulaire pour la therapie genique
|
|
AU749032B2
(en)
|
1997-06-13 |
2002-06-20 |
Johns Hopkins University, The |
Therapeutic nanospheres
|
|
CA2242035C
(en)
|
1997-07-01 |
2004-11-23 |
Transgene S.A. |
Compositions useful for transferring therapeutically active substances into a target cell, and their use in gene therapy
|
|
ES2210081T3
(es)
|
1998-07-07 |
2004-07-01 |
Transgene S.A. |
Utilizacion de los marcos de lectura de la region e4 para la mejora de la expresion de genes.
|
|
EP1155120B1
(fr)
|
1999-02-22 |
2006-07-05 |
Transgene S.A. |
Procede d'obtention d'une preparation virale purifiee
|
|
US6511832B1
(en)
|
1999-10-06 |
2003-01-28 |
Texas A&M University System |
In vitro synthesis of capped and polyadenylated mRNAs using baculovirus RNA polymerase
|
|
WO2001080897A2
(en)
|
2000-04-21 |
2001-11-01 |
Vical Incorporated |
Compositions and methods for in vivo delivery of polynucleotide-based therapeutics
|
|
DK1385538T3
(da)
*
|
2001-04-05 |
2013-04-29 |
Univ Johns Hopkins |
Kimære vacciner omfattende det lumenale domæne fra LAMP-1 eller LAMP-2
|
|
US20070269457A1
(en)
|
2006-05-16 |
2007-11-22 |
The Buck Institute For Age Research |
Immunotherapeutic compositions and methods
|
|
EP2161279A1
(en)
|
2008-08-29 |
2010-03-10 |
Centre National de la Recherche Scientifique |
Synthetic peptides corresponding to overlapping neutralizing determinants in the CBD1 epitope induce broadly neutralizing antibodies
|
|
CN107617110A
(zh)
|
2009-08-26 |
2018-01-23 |
西莱克塔生物科技公司 |
诱导t细胞辅助的组合物
|
|
WO2011046996A2
(en)
*
|
2009-10-13 |
2011-04-21 |
The Johns Hopkins University |
Consensus sequence for influenza a virus
|
|
US20160185831A1
(en)
*
|
2011-06-14 |
2016-06-30 |
Immunomic Therapeutics, Inc. |
Nucleic acids for treatment of allergies
|
|
EP3808361A1
(en)
*
|
2012-06-15 |
2021-04-21 |
Immunomic Therapeutics, Inc. |
Nucleic acids for treatment of allergies
|
|
US20170304432A1
(en)
*
|
2014-06-23 |
2017-10-26 |
Immunomic Therapeutics, Inc. |
Nucleic acids for treatment of peanut allergies
|
|
WO2017020026A1
(en)
*
|
2015-07-30 |
2017-02-02 |
Modernatx, Inc. |
Concatemeric peptide epitopes rnas
|
|
KR102637960B1
(ko)
*
|
2017-04-22 |
2024-02-21 |
이뮤노믹 쎄라퓨틱스, 인크. |
개선된 lamp 구축물
|